Biotech Engineered to Meet Emergency Response Timelines

Finding a CRO partner that offers fully integrated in-house platforms for antibody engineering and cell line development while producing high-speed results and high-quality yields can be a challenge. Amid the COVID-19 pandemic, ATUM leveraged their suite of technologies, including a customized laboratory information management system (LIMS), a Design-Build-Test-Learn (DBTL) methodology known as “GPS,” and the Leap-In Transposase®️ platform, to deliver high-quality monoclonal antibodies (mAbs) and CHO cell lines for clients striving to produce SARS-CoV-2 therapeutics, diagnostics, and vaccines at unprecedented speeds. Download the full blog to learn more about each of these technologies and how they can be applied.